ZBHNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

ZIMMER BIOMET HOLDINGS, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026

$94.99+0.01 (+0.01%)

Close on Oct 19, 2026

Market cap: $18.31B
P/E (TTM): 23.1
Dividend yield: 1.01%

ZIMMER BIOMET HOLDINGS, INC. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31	FY 2007 2007-12-31
Revenue	8,232	7,679	7,394	6,940	6,827	6,128	7,982	7,933	7,803	7,668	5,998	4,673	4,623	4,472	4,452	4,220	4,095	4,121	3,898
Cost of Revenue	2,494	2,191	2,084	2,020	1,960	1,824	2,253	2,272	2,133	2,382	1,801	1,243	1,267	1,125	1,122	1,012	991	997	876
Gross Profit	5,738	5,487	5,310	4,920	4,867	4,303	5,730	5,661	5,670	5,287	4,197	3,424	3,337	3,347	3,330	3,208	3,105	3,124	3,022
Research & Development	459	437	459	406	436	323	449	392	370	366	269	187	203	226	238	219	206	192	183
Selling, General & Admin	3,257	2,930	2,839	2,762	2,843	2,713	3,344	3,379	3,105	2,945	2,284	1,751	1,749	1,807	1,834	1,759	1,729	1,704	1,517
Operating Expenses	–	–	–	–	–	–	–	–	–	–	5,531	3,636	3,555	2,299	2,306	2,291	2,086	2,034	1,894
Total Costs & Expenses	7,133	6,393	6,117	6,244	5,967	6,044	6,845	7,899	7,004	6,847	5,531	3,636	–	–	–	–	–	–	–
Operating Income	1,098	1,286	1,278	696	860	83	1,138	34	799	821	467	1,037	1,069	1,047	1,024	917	1,019	1,090	1,128
Interest Expense	–	–	–	–	–	–	–	–	328	358	287	63	70	73	55	60	22	–	–
Interest & Investment Income	–	–	–	–	–	–	–	–	2.20	2.90	9.40	12	16	16	10	3.70	1.80	–	–
Other Non-Operating Income	26	-31	-9.30	-128	12	24	-4.80	-16	-9.40	-67	-37	-47	–	–	–	–	–	–	–
Merger & Restructuring Charges	–	–	–	–	32	–	–	–	17	91	196	–	–	–	–	–	–	–	–
Asset Impairment Charges	0	0	0	293	16	503	70	980	332	31	–	0	0	96	–	204	73	0	0
Gain (Loss) on Investments	15	-42	-19	-117	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	–	–	–	–	–	–	–	–	–	–	19	–	–	–	–	–	–	–	–
Legal Settlements	-23	-31	-22	-66	-201	-166	-53	–	–	–	–	–	–	–	–	–	–	–	–
Pretax Income	831	1,037	1,067	404	499	-105	906	-271	465	400	153	939	1,008	990	979	860	998	1,122	1,132
Income Tax Expense	126	131	42	112	54	-96	-226	108	-1,349	95	7.00	220	230	237	219	263	281	272	358
Income from Continuing Operations	705	905	1,025	290	445	-11	–	–	–	–	–	–	–	–	–	–	–	–	–
Income from Discontinued Operations	–	0	–	-59	-43	-128	–	–	–	–	–	–	–	–	–	–	–	–	–
Net Income incl. Noncontrolling Interests	705	905	1,025	232	402	-137	1,132	-379	1,813	305	146	719	779	753	760	597	717	850	774
Minority Interest in Earnings	–	–	–	–	0.50	1.50	-0.10	-0.10	-0.40	-1.30	-0.80	-1.10	-1.80	-2.10	-0.80	–	0	0.90	0.50
Net Income	705	904	1,024	231	402	-139	1,132	-379	1,814	306	147	720	780	755	761	597	717	849	773
EPS (Basic)(per share)	3.56	4.45	4.91	1.10	1.93	-0.67	5.52	-1.86	8.98	1.53	0.78	4.26	4.60	4.32	4.05	2.98	3.34	3.73	3.28
EPS (Diluted)(per share)	3.55	4.43	4.88	1.10	1.91	-0.67	5.47	-1.86	8.90	1.51	0.77	4.20	4.54	4.29	4.03	2.97	3.32	3.72	3.26
Shares Outstanding (Basic, Weighted)(shares)	198	203	209	210	209	207	205	204	202	200	187	169	170	175	188	200	215	227	236
Shares Outstanding (Diluted, Weighted)(shares)	199	204	210	210	210	207	207	204	204	202	190	172	172	176	189	201	216	228	238
Dividend per Share(per share)	0.96	0.96	0.96	0.96	0.96	0.96	0.96	0.96	0.96	0.96	0.88	0.88	0.80	0.54	0.18	–	–	–	–
EBITDA	2,192	2,282	2,229	1,623	1,798	982	2,144	1,074	1,862	1,860	1,180	1,413	1,427	1,411	1,384	1,257	1,356	1,365	1,358
Net Interest Income	-293	-218	-201	-165	-208	-212	-227	-289	-325	-355	–	–	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 69.9%
Operating margin: 14.2%
Net margin: 9.5%
Return on equity, FY2025: 5.6%

Financial strength

Current ratio: 1.69
Debt to equity: 0.59
Debt to assets: 32.8%
Cash to current liabilities: 13.6%

Valuation

P/E ratio: 23.1
Price to sales: 2.15
Price to book: 1.45
Dividend yield: 1.01%